Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.
Cancers (Basel). 2023 Mar 26;15(7):1980. doi: 10.3390/cancers15071980.
Cancers (Basel). 2023.
PMID: 37046641
Free PMC article.
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region.
Maruzzo M, Basso U, Borsatti E, Evangelista L, Alongi F, Caffo O, Maines F, Galuppo S, De Vivo R, Zustovich F, Palleschi D, Zivi A, Sava T, Sorarù M, Iacovelli R, Nicodemo M, Baier S, Fratino L, Zagonel V.
Maruzzo M, et al. Among authors: palleschi d.
Clin Genitourin Cancer. 2019 Feb;17(1):e187-e194. doi: 10.1016/j.clgc.2018.10.013. Epub 2018 Oct 26.
Clin Genitourin Cancer. 2019.
PMID: 30448106
Item in Clipboard
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.
Maruzzo M, Pierantoni F, Bortolami A, Palleschi D, Zivi A, Nicodemo M, Sartori D, De Vivo R, Zustovich F, Bimbatti D, Pastorelli D, Vultaggio GD, Soraru' M, Ballestrin M, Modonesi C, Randisi P, Barile C, Perri G, Basso U, Zagonel V.
Maruzzo M, et al. Among authors: palleschi d.
Target Oncol. 2022 Jul;17(4):467-474. doi: 10.1007/s11523-022-00892-z. Epub 2022 Jun 25.
Target Oncol. 2022.
PMID: 35751733
Free PMC article.
Item in Clipboard
The role of systemic and targeted therapies in brain metastases.
Franceschi E, Bartolotti M, Poggi R, Di Battista M, Palleschi D, Brandes AA.
Franceschi E, et al. Among authors: palleschi d.
Expert Rev Anticancer Ther. 2014 Jan;14(1):93-103. doi: 10.1586/14737140.2014.856760. Epub 2013 Nov 26.
Expert Rev Anticancer Ther. 2014.
PMID: 24308678
Review.
Item in Clipboard
Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach.
Fontanella C, Giorgi CA, Russo S, Angelini S, Nicolardi L, Giarratano T, Frezzini S, Pestrin M, Palleschi D, Bolzonello S, Parolin V, Haspinger ER, De Rossi C, Greco F, Gerratana L.
Fontanella C, et al. Among authors: palleschi d.
Crit Rev Oncol Hematol. 2022 Dec;180:103848. doi: 10.1016/j.critrevonc.2022.103848. Epub 2022 Oct 17.
Crit Rev Oncol Hematol. 2022.
PMID: 36257536
Free article.
Review.
Item in Clipboard
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Pasello G, Fabricio ASC, Del Bianco P, Salizzato V, Favaretto A, Piccin L, Zustovich F, Fabozzi A, De Rossi C, Pigozzo J, De Nuzzo M, Cappelletto E, Bonanno L, Palleschi D, De Salvo GL, Guarneri V, Gion M, Chiarion-Sileni V.
Pasello G, et al. Among authors: palleschi d.
J Transl Med. 2024 Mar 5;22(1):242. doi: 10.1186/s12967-024-04920-6.
J Transl Med. 2024.
PMID: 38443899
Free PMC article.
Item in Clipboard
Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study.
Musolino A, Michiara M, Conti GM, Boggiani D, Zatelli M, Palleschi D, Bella MA, Sgargi P, Di Blasio B, Ardizzoni A.
Musolino A, et al. Among authors: palleschi d.
J Clin Oncol. 2012 Jul 1;30(19):2362-8. doi: 10.1200/JCO.2011.37.6434. Epub 2012 May 14.
J Clin Oncol. 2012.
PMID: 22585698
Item in Clipboard
Cite
Cite